Two Sigma Advisers’s St Jude Medical STJ Stock Holding History
Bought
Maintained
Sold
Other funds holding STJ
FPF
JWA
AIM
Two Sigma Advisers's STJ Position: Q1 2017 in Review
Two Sigma Advisers sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 475,470 shares — an estimated $38.1M sold.
Two Sigma Advisers first reported a position in STJ in Q1 2014 and held it in 12 quarters. The position peaked at $83.1M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.
- Two Sigma Advisers reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
- Two Sigma Advisers sold 475,470 St Jude Medical shares in Q1 2017, an estimated $38.1M.
- Two Sigma Advisers first reported a position in St Jude Medical in Q1 2014 and held it in 12 quarters.
- Two Sigma Advisers's St Jude Medical position peaked at $83.1M in Q2 2016.
- 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.
Based on Two Sigma Advisers's 13F filing for Q1 2017, filed 15 May 2017.